Hot Features
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575,... AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.07 | 1.31332082552 | 5.33 | 6.79 | 5.16 | 8219555 | 6.03393501 | CS |
| 4 | 0.79 | 17.136659436 | 4.61 | 6.79 | 3.94 | 9293770 | 5.11566977 | CS |
| 12 | 1.84 | 51.6853932584 | 3.56 | 6.79 | 3.22 | 6076487 | 4.52718134 | CS |
| 26 | 1.94 | 56.0693641618 | 3.46 | 6.79 | 2.745 | 5016835 | 4.14895809 | CS |
| 52 | 3.28 | 154.716981132 | 2.12 | 6.79 | 2.09 | 5421392 | 4.25632037 | CS |
| 156 | -1.41 | -20.704845815 | 6.81 | 8.05 | 1.8906 | 3369724 | 4.03909083 | CS |
| 260 | -21.3 | -79.7752808989 | 26.7 | 27.4603 | 1.8906 | 2859728 | 6.42502851 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.